Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
Clinical trial NCT07449754 · RECRUITING
Trial details
- NCT number
- NCT07449754
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-12
- Primary completion
- 2029-09-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.